Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Fridlender, Zvi G ^a,b   Sun, Jing ^b   Mishalian, Inbal ^a   Singhal, Sunil ^b   Cheng, Guanjun ^b   Kapoor, Veena ^b   Horng, Wenhwai ^c   Fridlender, Gil ^a   Bayuh, Rachel ^a   Worthen, G Scott ^b   Albelda, Steven M ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 10; CATHEPSIN G; CD9 ANTIGEN; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEUKOCYTE ELASTASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 5; MYELOBLASTIN; MYELOPEROXIDASE; RANTES; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULOTROPIN; TRANSCRIPTOME;

ACTN 1 GENE; ACTN 4 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; ATR GENE; B LYMPHOCYTE; BONE MARROW NEUTROPHIL; CAMP GENE; CCL12 GENE; CCL2 GENE; CCL3 GENE; CCL4 GENE; CCL7 GENE; CCL8 GENE; CD11B GENE; CD9 GENE; CELL POPULATION; CHEK 1 GENE; CHEK 2 GENE; CONTROLLED STUDY; CXCL1 GENE; CXCL10 GENE; CXCL2 CHEMOKINE GENE; DOWN REGULATION; FIBRINOLYSIS; GENE; GENE EXPRESSION PROFILING; GRANULOCYTE; ICAM 1 GENE; INTERLEUKIN 6 GENE; IRAK 2 GENE; LACTOFERRIN GENE; LCP 1 GENE; MACROPHAGE; MDM 2 GENE; MHC II COMPLEX GENE; MMP 13 GENE; MMP 14 GENE; MMP8 GENE; MMP9 GENE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NEUTROPHIL; NGAL GENE; NONHUMAN; P53 GENE; PGLYRP GENE; PHAGOCYTOSIS; PROTEIN EXPRESSION; RAF 1 GENE; RANTES GENE; RESPIRATORY BURST; STRUCTURAL GENE; SUPPRESSOR CELL; T LYMPHOCYTE; TALIN 1 GENE; TIMP 1 GENE; TLR 1 GENE; TLR 4 GENE; TOLL LIKE RECEPTOR GENE; TRANSCRIPTOMICS; TREM 1 GENE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR ASSOCIATED NEUTROPHIL; UPREGULATION; VEGF GENE; ANIMAL; BONE MARROW CELL; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; IMMUNITY; IMMUNOLOGY; NEOPLASM; PATHOLOGY;

ANIMALIA; MUS;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTES; IMMUNITY; MICE; MYELOID CELLS; NEOPLASMS; NEUTROPHILS; RESPIRATORY BURST; RNA, MESSENGER; TRANSCRIPTOME;

EID: 84863116466     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031524     Document Type: Article

References (54)

1. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A, (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555.
2. Balkwill F, Coussens LM, (2004) Cancer: An inflammatory link. Nature 431: 405-406.
3. Yunping L, He Z, Krueger J, Kaplan C, Sung-Hyung L, et al. (2006) Targeting tumor-associated macrophages as a novel strategy against breast cancer. Journal of Clinical Investigation 116: 2132-2141.
4. Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, et al. (2009) Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 16: 183-194.
5. Jablonska J, Leschner S, Westphal K, Lienenklaus S, Weiss S, (2010) Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Invest 120: 1151-1164.
6. Pekarek LA, Starr BA, Toledano AY, Schreiber H, (1995) Inhibition of tumor growth by elimination of granulocytes. J Exp Med 181: 435-440.
7. Shojaei F, Singh M, Thompson JD, Ferrara N, (2008) Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression. Proceedings of the National Academy of Sciences 105: 2640-2645.
8. Tazawa H, Okada F, Kobayashi T, Tada M, Mori Y, et al. (2003) Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am J Pathol 163: 2221-2232.
9. Schmielau J, Finn OJ, (2001) Activated granulocytes and granulocyte-derived Hydrogen Peroxide are the underlying mechanism of suppression of T-Cell function in advanced cancer patients. Cancer Res 61: 4756-4760.
10. Nozawa H, Chiu C, Hanahan D, (2006) Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proceedings of the National Academy of Sciences 103: 12493-12498.
11. Piccard H, Muschel RJ, Opdenakker G, (2011) On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit Rev Oncol Hematol.
12. Kobayashi Y, (2008) The role of chemokines in neutrophil biology. Front Biosci 13: 2400-2407.
13. Wang LC, Thomsen L, Sutherland R, Reddy CB, Tijono SM, et al. (2009) Neutrophil influx and chemokine production during the early phases of the antitumor response to the vascular disrupting agent DMXAA (ASA404). Neoplasia 11: 793-803.
14. Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, et al. (2010) Myeloid-derived suppressor cell heterogeneity and subset definition. Current Opinion in Immunology 22: 238-244.
15. Kusmartsev S, Nagaraj S, Gabrilovich DI, (2005) Tumor-Associated CD8+ T Cell Tolerance Induced by Bone Marrow-Derived Immature Myeloid Cells. J Immunol 175: 4583-4592.
16. Raymond F, Metairon S, Borner R, Hofmann M, Kussmann M, (2006) Automated target preparation for microarray-based gene expression analysis. Anal Chem 78: 6299-6305.
17. Rajeevan MS, Vernon SD, Taysavang N, Unger ER, (2001) Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn 3: 26-31.
18. Bosotti R, Locatelli G, Healy S, Scacheri E, Sartori L, et al. (2007) Cross platform microarray analysis for robust identification of differentially expressed genes. BMC Bioinformatics 8 (Suppl 1): S5.
19. Huang LT, Paredes CJ, Papoutsakis ET, Miller WM, (2007) Gene expression analysis illuminates the transcriptional programs underlying the functional activity of ex vivo-expanded granulocytes. Physiol Genomics 31: 114-125.
20. Borregaard N, Sorensen OE, Theilgaard-Monch K, (2007) Neutrophil granules: a library of innate immunity proteins. Trends Immunol 28: 340-345.
21. Lambeth JD, (2004) NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189.
22. Theilgaard-Monch K, Jacobsen LC, Borup R, Rasmussen T, Bjerregaard MD, et al. (2005) The transcriptional program of terminal granulocytic differentiation. Blood 105: 1785-1796.
23. Sawanobori Y, Ueha S, Kurachi M, Shimaoka T, Talmadge JE, et al. (2008) Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 111: 5457-5466.
24. Danial NN, Korsmeyer SJ, (2004) Cell death: critical control points. Cell 116: 205-219.
25. Gregory AD, Houghton AM, (2011) Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res 71: 2411-2416.
26. Ashtekar A, Bhaskar S, (2003) Poly's plea: membership to the club of APC's. Trends in Immunology 24: 485-490.
27. Nagaraj S, Schrum AG, Cho HI, Celis E, Gabrilovich DI, (2010) Mechanism of T cell tolerance induced by myeloid-derived suppressor cells. J Immunol 184: 3106-3116.
28. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI, (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 181: 5791-5802.
29. Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, et al. (2008) Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111: 4233-4244.
30. Gabrilovich DI, Nagaraj S, (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162-174.
31. Opdenakker G, Van Damme J, (1992) Chemotactic factors, passive invasion and metastasis of cancer cells. Immunol Today 13: 463-464.
32. Zhelev DV, Alteraifi A, (2002) Signaling in the Motility Responses of the Human Neutrophil. Ann Biomed Eng 30: 356-370.
33. Shen L, Smith JM, Shen Z, Eriksson M, Sentman C, et al. (2007) Inhibition of human neutrophil degranulation by transforming growth factor-beta. Clinical and Experimental Immunology 149: 155-161.
34. Ashtekar AR, Saha B, (2003) Poly's plea: membership to the club of APCs. Trends Immunol 24: 485-490.
35. Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, et al. (2000) The neutrophil as a cellular source of chemokines. Immunological Reviews 177: 195-203.
36. Reiman JM, Kmieciak M, Manjili MH, Knutson KL, (2007) Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol 17: 275-287.
37. van Gisbergen KP, Geijtenbeek TB, van Kooyk Y, (2005) Close encounters of neutrophils and DCs. Trends Immunol 26: 626-631.
38. Abi Abdallah DS, Egan CE, Butcher BA, Denkers EY, (2011) Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation. Int Immunol 23: 317-326.
39. Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A, et al. (2001) The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 97: 339-345.
40. Kousis PC, Henderson BW, Maier PG, Gollnick SO, (2007) Photodynamic Therapy Enhancement of Antitumor Immunity Is Regulated by Neutrophils. Cancer Res 67: 10501-10510.
41. White ES, Strieter RM, Arenberg DA, (2002) Chemokines as therapeutic targets in non-small cell lung cancer. Curr Med Chem Anticancer Agents 2: 403-417.
42. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, et al. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10: 942-949.
43. Ueha S, Shand FH, Matsushima K, (2011) Myeloid cell population dynamics in healthy and tumor-bearing mice. Int Immunopharmacol 11: 783-788.
44. Eash KJ, Greenbaum AM, Gopalan PK, Link DC, (2010) CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J Clin Invest 120: 2423-2431.
45. Fan X, Patera AC, Pong-Kennedy A, Deno G, Gonsiorek W, et al. (2007) Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8. J Biol Chem 282: 11658-11666.
46. Appelberg R, (1992) Mycobacterial infection primes T cells and macrophages for enhanced recruitment of neutrophils. J Leukoc Biol 51: 472-477.
47. Kobayashi Y, (2006) Neutrophil infiltration and chemokines. Critical Reviews in Immunology 26: 307-315.
48. Morales J, Kmieciak M, Knutson K, Bear H, Manjili M, (2010) GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells. Breast Cancer Research and Treatment 123: 39-49.
49. Dolcetti L, Peranzoni E, Ugel S, Marigo I, Fernandez Gomez A, et al. (2010) Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. European Journal of Immunology 40: 22-35.
50. Wilderman MJ, Sun J, Jassar AS, Kapoor V, Khan M, et al. (2005) Intrapulmonary IFN-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung. Cancer Res 65: 8379-8387.
51. Nick JA, Young SK, Brown KK, Avdi NJ, Arndt PG, et al. (2000) Role of p38 Mitogen-Activated Protein Kinase in a Murine Model of Pulmonary Inflammation. The Journal of Immunology 164: 2151-2159.
52. Fridlender ZG, Kapoor V, Buchlis G, Cheng G, Sun J, et al. (2011) Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells. Am J Respir Cell Mol Biol 44: 230-237.
53. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, et al. (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507.
54. Carretero J, Shimamura T, Rikova K, Jackson AL, Wilkerson MD, et al. (2010) Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors. Cancer Cell 17: 547-559.